IVM is an alternative for patients with PCO after failed conventional IVF attempt

J Assist Reprod Genet. 2011 Jun;28(6):495-9. doi: 10.1007/s10815-011-9591-z. Epub 2011 Jun 7.

Abstract

Purpose: To determine if IVM of oocytes from unstimulated cycle is a treatment option for patients who did not deliver after standard IVF-ET.

Method: Twenty three women with PCO, thirteen of them with normal cycles and all <35 years old, who failed IVF served as their own control. During the control IVF cycle patients were stimulated with 1730.7 ± 639.5 IU recombinant FSH, a long Buserelin acetate protocol was used and embryo transfer was performed on day 2 or 3 after ICSI. After failed IVF immature oocytes were aspirated transvaginally from antral follicles during spontaneous menstrual cycle. Embryo transfer was performed 2 or 3 days later.

Result: 11.4 ± 4.8 mature oocytes and 6.7 ± 3.2 embryos were produced with IVF, which served as the control, compared to 9.7 ± 4.5 mature oocytes and 6.2 ± 3.2 embryos with IVM. There was one clinical pregnancy in the IVF group which did not result in a live birth where as five singleton and one pair of twins with healthy live births and one miscarriage in the IVM group.

Conclusion: IVM does not involve ovarian stimulation with possible financial and health consequences. İt may be an useful treatment after unsuccessful IVF.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Buserelin / therapeutic use
  • Embryo Transfer / methods
  • Female
  • Follicle Stimulating Hormone / administration & dosage
  • Follicle Stimulating Hormone / therapeutic use*
  • Humans
  • In Vitro Oocyte Maturation Techniques / methods*
  • Infertility, Female / etiology
  • Infertility, Female / therapy*
  • Oocytes / growth & development*
  • Polycystic Ovary Syndrome / complications*
  • Pregnancy
  • Sperm Injections, Intracytoplasmic / methods*

Substances

  • Follicle Stimulating Hormone
  • Buserelin